The MYCN-regulated miR-17∼92 cluster targets nuclear hormone receptors
An NHR signature is associated with neural differentiation and patient survival
The induction of MYCN or miR-17∼92 attenuates glucocorticoid receptor signaling
Combined MYCN inhibition and GR activation drive differentiation and ease tumor burden